2022
DOI: 10.29011/2575-9760.001554
|View full text |Cite
|
Sign up to set email alerts
|

Axillary Management after Neoadjuvant Chemotherapy; A Review of How and When?

Abstract: Axillary management in breast cancer has multiple paradigm changes. From standard axillary dissection level 1 and level 2 to sentinel lymph node biopsy in early-stage breast cancer. Now sentinel lymph node biopsy trend to use after neoadjuvant treatment to reduce the morbidity from standard axillary dissection. This review is collecting information on axillary management after neoadjuvant chemotherapy. Such as how to improve the accuracy of SLN in initial clinical nodal negative and initial clinical nodal posi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 37 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?